Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramón Cacabelos

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Life (Basel, Switzerland)|September 23, 2022
New Paradigms in Pharmaceutical DevelopmentRamón Cacabelos
Life (Basel, Switzerland)|January 8, 2025
Progress in Pharmaceutical Sciences and Future ChallengesRamón Cacabelos
Expert Opinion on Drug Metabolism & Toxicology|June 11, 2020
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's diseaseRamón Cacabelos
Molecular Diagnosis & Therapy|December 15, 2007
Pharmacogenetic basis for therapeutic optimization in Alzheimer's diseaseRamón Cacabelos
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Pharmacogenomics in Alzheimer's diseaseRamón Cacabelos
Expert Review of Molecular Diagnostics|September 8, 2009
Pharmacogenomics and therapeutic strategies for dementiaRamón Cacabelos
Mini Reviews in Medicinal Chemistry|October 9, 2002
Pharmacogenomics in Alzheimer's diseaseRamón Cacabelos
International Journal of Molecular Sciences|March 10, 2017
Parkinson's Disease: From Pathogenesis to PharmacogenomicsRamón Cacabelos
Pharmacogenomics|August 29, 2003
The application of functional genomics to Alzheimer's diseaseRamón Cacabelos
Expert Opinion on Pharmacotherapy|October 4, 2005
Pharmacogenomics and therapeutic prospects in Alzheimer's diseaseRamón Cacabelos
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Life (Basel, Switzerland)|September 23, 2022
New Paradigms in Pharmaceutical DevelopmentRamón Cacabelos
Life (Basel, Switzerland)|January 8, 2025
Progress in Pharmaceutical Sciences and Future ChallengesRamón Cacabelos
Expert Opinion on Drug Metabolism & Toxicology|June 11, 2020
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's diseaseRamón Cacabelos
Molecular Diagnosis & Therapy|December 15, 2007
Pharmacogenetic basis for therapeutic optimization in Alzheimer's diseaseRamón Cacabelos
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Pharmacogenomics in Alzheimer's diseaseRamón Cacabelos
Expert Review of Molecular Diagnostics|September 8, 2009
Pharmacogenomics and therapeutic strategies for dementiaRamón Cacabelos
Mini Reviews in Medicinal Chemistry|October 9, 2002
Pharmacogenomics in Alzheimer's diseaseRamón Cacabelos
International Journal of Molecular Sciences|March 10, 2017
Parkinson's Disease: From Pathogenesis to PharmacogenomicsRamón Cacabelos
Pharmacogenomics|August 29, 2003
The application of functional genomics to Alzheimer's diseaseRamón Cacabelos
Expert Opinion on Pharmacotherapy|October 4, 2005
Pharmacogenomics and therapeutic prospects in Alzheimer's diseaseRamón Cacabelos
Pageof 10